Eli Lilly is expanding its presence in hair loss treatments through an investment in AI drug discovery company Absci, supporting development of an AI-designed antibody program for hair loss and endometriosis.
Eli Lilly Dives Into Hair Loss Treatments with Investment in AI Startup Absci
Share: